Status:
TERMINATED
Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
To test the effect of the research study drug, inhaled fluticasone on lung function in exercising patients with Chronic Obstructive Pulmonary Disease (COPD).
Eligibility Criteria
Inclusion
- 40 years and older
- Clinical diagnosis of COPD for greater than one year
- History of cigarette smoking
Exclusion
- Other lung diseases (not including COPD), such as asthma
- A condition that could interfere with your ability to perform exercise tests
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00387036
Start Date
December 1 2006
End Date
July 1 2009
Last Update
January 21 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.